Form 4: AngioDynamics CEO James Clemmer Buys 10,000 Shares
SEC Form 4 Filing
AngioDynamics' CEO, James C. Clemmer, recently purchased 10,000 shares of the company's common stock at an average price of $6.70 per share.
Summary
- On April 8, 2024, James C. Clemmer, the President and CEO of AngioDynamics Inc., acquired 10,000 shares of common stock.
- The shares were purchased at a weighted average price of $6.70, with individual transactions ranging from $6.64 to $6.76.
- Following this transaction, Clemmer directly owns 539,066 shares of AngioDynamics Inc.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. The CEO's purchase of shares suggests confidence in the company, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Executive stock purchases are common and closely watched as indicators of management's sentiment about the company's prospects. It is a common practice for executives to buy or sell shares of their own company, and these transactions are reported to the SEC.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/08/2024 | Date of the transaction: James C. Clemmer purchased 10,000 shares of AngioDynamics Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.